| Application no. and date | 20808308.9 (espacenet) (Federated) (European Patent Register), 20201106 | | Patent/reg. no. and date | DK/EP 3962601, 20230531 | | Publication date | 20220309 | | Priority no. and date | EP 19207578, 20191107, US 202017090457, 20201105 | | EP pub. no. and date |
EP 3962601 20220309 | | Effective date | | | Applicant/owner | Lophora ApS, Gyldenlundsvej 21, 2920 Charlottenlund, DK | | Applicant ref. no. | P1689DKEP | | Inventor | KRISTENSEN, Jesper Langgaard, Korsgade 9, 1. tv, 2200 København N, DK,
JENSEN, Anders Asbjørn, Griffenfeldsgade 37 C, 03.0003, 2200 København N, DK,
MÄRCHER-RØRSTED, Emil, Poppelgade 9, 1. th, 2200 København N, DK,
LETH-PETERSEN, Sebastian, Asger Rygs gade 2A, 1727 København V, DK | | Representative | COPA COPENHAGEN PATENTS K/S, Rosenvængets Allé 25, 2., 2100 København Ø | | Opponent | | | IPC Class | A61K 31/451 (2006.01) , A61P 25/24 (2006.01) , C07D 211/22 (2006.01) | | Title | 5-HT2A-agonister til anvendelse til behandling af depression | | Int. application no. | EP2020081357 | | Int. publication no. | WO2021089824 | | Related patent (certificate) | | | Status | DK/EP patent | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
